Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

The study concluded that the new wound model can be used to evaluate skin regeneration and nerve growth.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

A woman had an allergic skin reaction to a hair loss treatment containing minoxidil and should not use it.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Regenerative medicine could revolutionize aesthetic surgery, but needs careful validation and ethical use.

Smaller nanoemulsions can penetrate skin and hair follicles better, which may be useful for delivering drugs and vaccines through the skin.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

Skin organoids can mimic human skin responses to injury and inflammation, making them useful for studying skin diseases and testing treatments.

Blue light therapy is promising for skin and hair conditions but needs more research for widespread use.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Hypochlorous acid is a safe, effective antimicrobial with potential in various medical fields, but more research is needed to improve its stability and use.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

Targeting the endocannabinoid system might help reduce hair pulling in trichotillomania.

Upadacitinib effectively treats pyoderma gangrenosum.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Oral minoxidil can cause dry mouth, but switching to topical minoxidil may prevent this side effect.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.